ID   FMA3
AC   CVCL_0264
SY   FMA-3; FMA/3
DR   MCCL; MCC:0000155
DR   Wikidata; Q54835079
RX   DOI=10.2220/biomedres.5.19;
RX   PubMed=3934308;
RX   PubMed=8547652;
CC   Sequence variation: Mutation; MGI; MGI:96677; Kit; Simple; p.Thr577_His583del; Zygosity=Unspecified; Note=Constitutive activation (PubMed=8547652).
CC   Breed/subspecies: LAF1.
DI   NCIt; C21632; Mouse mast cell neoplasm
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_UZ20 ! FMA
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 7
//
RX   DOI=10.2220/biomedres.5.19;
RA   Yanagisawa M., Hasegawa H., Ichiyama A., Hosoda S., Nakamura W.;
RT   "Comparison of serotonin-producing murine mastocytomas, P-815 and
RT   FMA3: determination of tryptophan hydroxylase, aromatic L-amino acid
RT   decarboxylase, and cellular concentration of tryptophan, 5-
RT   hydroxytryprophan, 5-hydroxytryptamine and 5-hydroxyindoleacetic
RT   acid.";
RL   Biomed. Res. 5:19-28(1984).
//
RX   PubMed=3934308; DOI=10.1016/S0022-2275(20)34287-5;
RA   Yoshioka S., Nakashima S., Okano Y., Hasegawa H., Ichiyama A.,
RA   Nozawa Y.;
RT   "Phospholipid (diacyl, alkylacyl, alkenylacyl) and fatty acyl chain
RT   composition in murine mastocytoma cells.";
RL   J. Lipid Res. 26:1134-1141(1985).
//
RX   PubMed=8547652; DOI=10.1182/blood.V87.1.273.273;
RA   Tsujimura T., Morimoto M., Hashimoto K., Moriyama Y., Kitayama H.,
RA   Matsuzawa Y., Kitamura Y., Kanakura Y.;
RT   "Constitutive activation of c-kit in FMA3 murine mastocytoma cells
RT   caused by deletion of seven amino acids at the juxtamembrane domain.";
RL   Blood 87:273-283(1996).
//